Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01, its lead clinical-stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. ACP-01 is in a Phase 2 clinical trial in Canada and the United States. Its technology includes methods for collecting the synergetic cell population and manufacturing a personalized regenerative therapy that can be administered to a patient within seven days of the initial cell collection. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd. and PreCerv Inc.

TSXV:HEM - Post by User

Hemostemix Inc > We need some positive news...

<< Previous

Bullboard Posts

Next >>

Comment by milstogoon Feb 10, 2021 10:08pm

148 Views

Post# 32533963

RE:RE:We need some positive news...

For those wondering what Walterthedog is referring to: re: Thomas pumping Hem on the CEO Board: Here is the the last posting he did & promising the video to clarify posted Jan 28 which he never posted or followed up on and I was looking forward to seeing what he had to say too. (also, I noticed.. all the posters on ceo.ca/hem who had been "soft" pumping Hem suddenly disappeared after Thomas's last post too.)

 		@VerificationCode lets see what Mr. Smeek has to say before jumping to conclusions\
 		5
from #hem,  		28 Jan 2021, 10:53

 				 
@DocHolidayI will but he will likely not be at liberty to discuss the trial same as last time
 		0
from #hem,  		28 Jan 2021, 11:05

 				 
@ProfitWhat's up Doc? @ticotime2020 isn't privy to anything else the rest of us are. Thomas will share what he legally can, the rest is speculation. That's why we're all speculators lol. Well except you maybe.
 		2
from #hem,  		28 Jan 2021, 11:08

 				 
@InvestEasemaybe it's not what you ask but how you ask him
 		1
from #hem,  		28 Jan 2021, 11:09

 				 
@DocHolidayBut you're right its all speculation. Ill wait and see and speculate like everyone else
 		0
from #hem,  		28 Jan 2021, 11:12

 				 
@DocHolidayHave a good day gents and get your panties out of a bunch. Im not here to bash. Just trying to interpret this joke of an NR that should have been 2 pages instead of 2 sentences
 		1
from #hem,  		28 Jan 2021, 11:14

 				 
@HEM_CEOGood morning to all. Just read a few notes and thought it may be helpful to provide some colour. 
 		22
from #hem,  		28 Jan 2021, 11:16

 				 
@PakG1@HEM_CEO IN THE HOUSE!!! :)
 		0
from #hem,  		28 Jan 2021, 11:16

 				 
@BearTankgood morning Thomas @HEM_CEO
 		0
from #hem,  		28 Jan 2021, 11:23

 				 
@HEM_CEOMid point results would have been an analyses of 42 patients who were followed for 26 weeks. Whereas the analyses will be based on 65 patients who have completed the clinical trial at the end of March 2021. 
 		5
from #hem,  		28 Jan 2021, 11:36

 				 
@VerificationCodeSo this is more like endpoint results?
 		1
from #hem,  		28 Jan 2021, 11:36

 				 
@HEM_CEOYup!
 		4
from #hem,  		28 Jan 2021, 11:37

 				 
@HEM_CEOWhich enables the company to save time and expenses related to the phase II and, subject to FDA approval, commence the phase III.
 		7
from #hem,  		28 Jan 2021, 11:38

 				 
@VerificationCodeWow thats amazing. Does this mean phase 2 midpoint results wont be analysed anymore and HEM is just going straight to endpoint?
 		3
from #hem,  		28 Jan 2021, 11:38

 				 
@HEM_CEOYup!
 		8
from #hem,  		28 Jan 2021, 11:38

 				 
@Profit^^^ !!!
 		1
from #hem,  		28 Jan 2021, 11:38

 				 
@VerificationCodegreat news! Thank you for the clarification. We may have to wait a bit longer but this is advancing quite well.
 		1
from #hem,  		28 Jan 2021, 11:39

 				 
@HEM_CEOIt is very good news. My pleasure! Yes, Subject to the above caveats (successful phase II and FDA approval of phase III). 
 		7
from #hem,  		28 Jan 2021, 11:41

 				 
@HEM_CEOThanks very much! Have a great day! Sincerely, Thomas
 		14
from #hem,  		28 Jan 2021, 11:42

 				 
@FantasyInvestorNice having a CEO that comes to the boards and talks with shareholders. Refreshing.
 		4
from #hem,  		28 Jan 2021, 11:44

 				 
@GreencorkBUY:Hem
 		5
from #hem,  		28 Jan 2021, 14:00

 				 
@MadssternGoooood morning beautiful HEM people 
 		2
from #hem,  		29 Jan 2021, 10:34

 				 
@JamesWoodPicks for feb $gnom $hem $vpt 
 		14
from @jameswood,  		30 Jan 2021, 12:18

 				 
@thebigstank Haha @docholiday .. guess you sold at a major loss... again
 		5
from #hem,  		30 Jan 2021, 16:08

 				 
@HEM_CEO@Docholiday: I’ll clarify in a couple videos this week. The historical data does not support your hypothesis. Sincerely, Thomas 
 		25
from #hem,  		31 Jan 2021, 01:00

 				 
@PakG1$HEM has a great CEO
 		5
from #hem,  		31 Jan 2021, 01:03

 				 
@HornetHaabuWow nothing better than to see the CEO chime in on a basher
 		7
from #hem,  		31 Jan 2021, 02:55

 				 
@JMAC90I don't think Doc ever sold. He has always needed validation from the board to feel good about his investment here. His repetitive need for an upside explanation, lead to no one wanting to hold his hand anymore. The next step was reverse psychology, and bash, in order to get validation once again. I'm sure, he's beyond excited to get the comfort from Thomas, when Hem_Ceo disagreed with his hypothesis. 